Press release
Postoperative Pain Pipeline Analysis Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Avenue Therapeutics, Concentric Analgesics, Oculis Pharma, Vivozon Pharma, Nevakar, Flexion Therapeutics, Lipo Cure
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 45+ key pharma and biotech companies are working on 50+ pipeline drugs in the Postoperative Pain therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years."Postoperative Pain Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Postoperative Pain Therapeutics Market.
The report provides a detailed description of the Postoperative Pain drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Postoperative Pain Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Postoperative Pain Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Postoperative Pain therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Postoperative Pain treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Postoperative Pain drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Postoperative Pain treatment market.
Learn More about the Clinical and Commercial Development Activities in the Postoperative Pain Therapeutics Domain @
https://www.delveinsight.com/report-store/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Postoperative Pain Therapeutics Analysis
There are approx. 50+ key companies developing therapies for Postoperative Pain. Currently, Vivozon Pharmaceutical Inc. is leading the therapeutics market with its Postoperative Pain drug candidates in the most advanced stage of clinical development.
Postoperative Pain Companies in the Therapeutics Market Include:
• Concentric Analgesics
• Oculis Pharma
• Vivozon Pharmaceutical Inc.
• Haisco Pharmaceutical Group
• Jiangsu Hengrui Pharmaceuticals Co., Ltd.
• Nevakar, Inc.
• Flexion Therapeutics
• Lipo Cure
• Site One Therapeutics
• Allay Therapeutics
• Bexson Biomedical
• In Situ Biologics
• Avenue Therapeutics
And Many Others
Emerging and Marketed Postoperative Pain Therapies Covered in the Report Include:
• VVZ-149: Vivozon Pharmaceutical Inc.
• CA-008: Concentric Analgesics
And Many More
Get an in-depth Assessment of the Emerging Therapies and Postoperative Pain Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Postoperative Pain Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Postoperative Pain pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical
Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Request for Sample PDF to Understand More About the Postoperative Pain Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Postoperative Pain Current Treatment Patterns
4. Postoperative Pain - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Postoperative Pain Late-Stage Products (Phase-III)
7. Postoperative Pain Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Postoperative Pain Discontinued Products
13. Postoperative Pain Product Profiles
14. Postoperative Pain Companies
15. Postoperative Pain Drugs
16. Dormant and Discontinued Products
17. Postoperative Pain Unmet Needs
18. Postoperative Pain Future Perspectives
19. Postoperative Pain Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Postoperative Pain Pipeline Analysis Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Avenue Therapeutics, Concentric Analgesics, Oculis Pharma, Vivozon Pharma, Nevakar, Flexion Therapeutics, Lipo Cure here
News-ID: 3344532 • Views: …
More Releases from DelveInsight Business Research LLP

Myelofibrosis Pipeline Report 2025 by DelveInsight: Key Insights into Clinical S …
DelveInsight's "Myelofibrosis Pipeline Insight" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in the Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelofibrosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Myelofibrosis…

Hemophilia Pipeline Landscape Report 2025: DelveInsight's Exclusive Report on Cu …
DelveInsight's "Hemophilia Pipeline Insight" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Hemophilia pipeline landscape. It covers the Hemophilia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hemophilia therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Hemophilia…

DelveInsight's NMIBC Pipeline 2025: Unveiling Drug Development Progress, Clinica …
DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non Muscle Invasive Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non Muscle Invasive Bladder Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive…

Hearing Loss Pipeline 2025 by DelveInsight: Exploring Novel Mechanisms of Action …
DelveInsight's "Hearing Loss Pipeline Insight" report provides comprehensive insights about 32+ companies and 35+ pipeline drugs in Hthe earing Loss pipeline landscape. It covers the Hearing Loss pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hearing Loss therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights!…
More Releases for Postoperative
Postoperative Acute Pain Market Trends, Treatments, and Global Forecast
Postoperative acute pain (POAP) remains one of the most significant challenges in clinical care, affecting nearly 80% of patients after surgery. Poorly managed pain can lead to complications such as delayed recovery, prolonged hospital stays, readmissions, and higher healthcare costs. Traditionally, opioid analgesics have been the cornerstone of treatment, but rising concerns around opioid dependency and adverse effects are fueling demand for safer, multimodal pain management approaches.
Download Full PDF Sample…
Postoperative Pain Therapeutics Market Innovations and Trends for 2032
The Postoperative Pain Therapeutics market has become an essential sector within the healthcare industry, particularly in the wake of increasing surgical procedures and the subsequent need for effective pain management solutions. This market encompasses a wide range of therapeutics designed to alleviate pain following surgical interventions, ensuring patient comfort and satisfaction during recovery. With a focus on improving patient outcomes, the postoperative pain therapeutics market has seen significant advancements, driven…
Postoperative Pain Therapeutics Market Analysis and Forecast (2024-2032)
The introduction serves as the foundational section of our analysis. It aims to provide a comprehensive overview of the Postoperative Pain Therapeutics Market, emphasizing its significance and the purpose of the analysis.
The Postoperative Pain Therapeutics Market plays a pivotal role in the healthcare industry. It addresses the critical need for effective pain management following surgical procedures, contributing to patient comfort and recovery. This market has witnessed substantial growth due to…
Postoperative Pain Therapeutics Market: An In-Depth Analysis
In the ever-evolving landscape of healthcare, the Postoperative Pain Therapeutics Market has emerged as a significant player. This market, valued at USD 0.88 billion in 2023, is driven by various factors such as the production and commercialization of new drugs, increased research and development activities, rising health concerns, enhanced diagnostics facilities, and a growing global population. With a projected compound annual growth rate (CAGR) of 9.3% between 2024 and 2032,…
Postoperative Nausea and Vomiting Management Market Rising focus on patient comf …
Global Postoperative Nausea and Vomiting Management Market Overview:
The Postoperative Nausea and Vomiting Management market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Postoperative Nausea and Vomiting Management market has experienced significant growth, driven by factors such as increasing consumer demand,…
Prevention and management of postoperative endophthalmitis
The decisive criterion of postoperative endophthalmitis after cataract operations or intravitreal injections is the contamination of the operating area and the instruments / implants with pathogens during the surgical procedure. In traditional operating theaters, the "sterility" is very limited and only given directly under the supply air ceiling. However, the surgical field is almost completely shielded from the ultra-clean air by the surgical microscope and the surgeon's head, so that…